References
- Nunns D, Mandal D. The chronically symptomatic vulva: prevalence in primary health care. Genitourin Med 1996; 72: 343–4
- Gates EA, Galask RP. Psychological and sexual functioning in women with vulvae vestibulitis. J Psychosom Obstet Gynaecol 2001; 22: 221–8
- Welsh B, Howard A, Cook K. Vulval itch. Aust Fam Physician 2004; 33: 505–10
- Fischer GO. The commonest causes of symptomatic vulvar disease: a dermatologist's perspective. Australas J Dermatol 1996; 37: 12
- Pincus SH. Vulvar dermatoses and pruritus vulvae. Dermatol clin 1992; 10: 297
- Foster DC. Vulvar disease. Obstet Gynecol 2002; 100: 145–63
- Fischer G, Spurrett B, Fischer A. The chronically symptomatic vulva: aetiology and management. Br J Obstet Gynaecol 1995; 102: 773–9
- Bracco GL, Carli P. Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation. J Reprod Med 1993; 38: 37–40
- Cattaneo A, De Marco A. Clobetasol vs. testosterone in the treatment of lichen sclerosus of the vulvar region. Minerva Ginecol 1992; 44: 567–71
- Polano MK. De toepasbaarheid van corticoid zalven en crèmes [The efficacy of topical steroids]. Ned Tijdschrift Geneeskd 1986; 14: 624–7
- Ferris DG, Hendrich J, Payne PM, Getts A, Rassekh R, Mathis D, et al. Office laboratory diagnosis of vaginitis. Clinician-performed tests compared with a rapid nucleic acid hybridization test. J Fam Pract 1995; 41: 575–81
- van Weel, C, König-Zahn, C, Touw Otten, FWMM, van Duyn, NP, Meyboom de Jong, B. Measuring functional health status with the COOP/WONCA charts, a manual. Groningen: North Centre for Health Problems; 1995.
- Marin MG, King R, Sfameni S, Dennerstein GJ. Adverse behavioral and sexual factors in chronic vulvar disease. Am J Obstet Genecol 2000; 183: 34